Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU – Get Free Report) shares gapped down before the market opened on Tuesday . The stock had previously closed at $80.14, but opened at $77.15. Direxion Daily S&P Biotech Bull 3x Shares shares last traded at $74.70, with a volume of 364,511 shares trading hands.
Direxion Daily S&P Biotech Bull 3x Shares Stock Performance
The business’s 50 day moving average price is $86.37 and its two-hundred day moving average price is $107.75.
Institutional Investors Weigh In On Direxion Daily S&P Biotech Bull 3x Shares
Large investors have recently modified their holdings of the stock. Dunhill Financial LLC bought a new stake in Direxion Daily S&P Biotech Bull 3x Shares during the third quarter worth about $46,000. Spire Wealth Management bought a new stake in Direxion Daily S&P Biotech Bull 3x Shares during the fourth quarter worth about $68,000. SBI Securities Co. Ltd. bought a new stake in Direxion Daily S&P Biotech Bull 3x Shares during the fourth quarter worth about $244,000. B. Riley Wealth Advisors Inc. bought a new stake in Direxion Daily S&P Biotech Bull 3x Shares during the third quarter worth about $279,000. Finally, SG Americas Securities LLC boosted its stake in Direxion Daily S&P Biotech Bull 3x Shares by 6.0% during the fourth quarter. SG Americas Securities LLC now owns 3,392 shares of the company’s stock worth $305,000 after acquiring an additional 193 shares in the last quarter.
About Direxion Daily S&P Biotech Bull 3x Shares
The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.
Featured Articles
- Five stocks we like better than Direxion Daily S&P Biotech Bull 3x Shares
- Low PE Growth Stocks: Unlocking Investment Opportunities
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- Investing in the High PE Growth Stocks
- Alphabet’s Officially In A Bear Market—Time To Buy?
- 3 Best Fintech Stocks for a Portfolio Boost
- D-Wave and Quantum Supremacy: Implications For Investors
Receive News & Ratings for Direxion Daily S&P Biotech Bull 3x Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Direxion Daily S&P Biotech Bull 3x Shares and related companies with MarketBeat.com's FREE daily email newsletter.